Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMarshalls Regulatory News (MSLH)

Share Price Information for Marshalls (MSLH)

Share Price is delayed by 15 minutes
Get Live Data
129.30    -1.60 (-1.22%)
Bid:
129.20
Ask:
129.60
Spread: 0.40 (0.31%)
Market Cap: £326.99m
MSLH Live PriceLast checked at - London Stock Exchange

Intraday Marshalls Share Chart

Board Appointment

29 Apr 2021 07:00

RNS Number : 9923W
Marshalls PLC
29 April 2021
 

29 April 2021

 

Marshalls plc

(the "Company" or "Marshalls")

 

Board Appointment

 

Justin Lockwood appointed as CFO

 

Marshalls plc, the specialist landscape products group, is pleased to announce the appointment of Justin Lockwood to the Board as Chief Financial Officer.

 

Justin is currently the Chief Financial Officer of International Personal Finance plc. He joined them in 2010 and held a number of senior finance roles prior to his appointment as CFO in 2017. Justin brings extensive experience of all aspects of financial management in large publicly listed companies.

 

Prior to International Personal Finance plc, Justin worked for Associated British Ports for four years in a senior finance role. His first role in industry was with Marshalls, between 2002 and 2006, where he worked in a variety of business unit and head office roles, including as finance director of Marshalls Clay Products before its disposal to Hanson plc. Justin is a chartered accountant, having qualified with PwC where he spent the first 10 years of his career.

 

Justin succeeds Jack Clarke who stepped down from the Board, and as Group Finance Director, on 31 March 2021. His appointment will take effect at a date to be agreed once his departure date from International Personal Finance plc has been finalised.

 

Martyn Coffey, CEO of Marshalls commented:

 

"We're delighted that Justin is joining the business. His rich, cross-sector experience, which includes time with Marshalls earlier in his career, will be an asset to the Board and help us capitalise on future growth opportunities and deliver our strategic objectives. In Justin, we're confident we've found an outstanding successor to Jack Clarke, who made a significant contribution to the sustained growth of Marshalls during his time with us."

 

Justin Lockwood commented:

 

"Marshalls is an exceptional business with strong heritage and a clear strategic vision. I'm delighted to be joining and look forward to working with Martyn, the Board and all of Marshalls' very dedicated colleagues"

 

There are no disclosures required pursuant to Listing Rule 9.6.13.

 

- Ends -

 

The information communicated in this announcement is inside information.

 

Enquiries:

 

Martyn Coffey, Chief Executive

Marshalls plc

+44 (0)1422 314777

Shiv Sibal, Company Secretary

Marshalls plc

+44 (0)1422 314767

Andrew Jaques

MHP Communications

+44 (0)20 3128 8540

Charlie Barker

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOAUWVARAWUSUUR
Date   Source Headline
12th Nov 202412:02 pmRNSDirector/PDMR Shareholding
12th Nov 202411:47 amRNSDirector/PDMR Shareholding
12th Nov 202411:44 amRNSDirector/PDMR Shareholding
31st Oct 202411:18 amRNSHolding(s) in Company
16th Oct 20247:00 amRNSQ3 Trading Update
15th Oct 20249:45 amRNSDirector/PDMR Shareholding
15th Oct 20249:43 amRNSDirector/PDMR Shareholding
15th Oct 20249:42 amRNSDirector/PDMR Shareholding
10th Sep 20244:59 pmRNSDirector/PDMR Shareholding
23rd Aug 20242:57 pmRNSDirector/PDMR Shareholding
16th Aug 202411:21 amRNSHolding(s) in Company
12th Aug 20247:00 amRNSHalf-year Report
25th Jul 20247:00 amRNSNotice of Interim Results
3rd Jun 20243:17 pmRNSDirector/PDMR Shareholding
15th May 20241:01 pmRNSResult of AGM
15th May 20247:00 amRNSTrading Statement
29th Apr 20243:25 pmRNSDirector/PDMR Shareholding - Correction
29th Apr 202411:45 amRNSDirector/PDMR Shareholding
19th Apr 20248:51 amRNSHolding(s) in Company
10th Apr 20242:03 pmRNSAnnual Financial Report
22nd Mar 202412:40 pmRNSDirector/PDMR Shareholding
19th Mar 20242:00 pmRNSDirector/PDMR Shareholding
19th Mar 20241:59 pmRNSDirector/PDMR Shareholding
19th Mar 20241:57 pmRNSDirector/PDMR Shareholding
19th Mar 20241:56 pmRNSDirector/PDMR Shareholding
18th Mar 202412:07 pmRNSDirector/PDMR Shareholding
18th Mar 20247:00 amRNSFinal Results
26th Feb 202410:36 amRNSDirector/PDMR Shareholding
15th Feb 20249:49 amRNSHolding(s) in Company
1st Feb 202411:59 amRNSHolding(s) in Company
31st Jan 20241:17 pmRNSHolding(s) in Company
18th Jan 20247:00 amRNSTrading Statement
21st Dec 20239:36 amRNSHolding(s) in Company
6th Dec 20237:00 amRNSCEO Succession
1st Dec 20233:08 pmRNSHolding(s) in Company
28th Nov 20233:17 pmRNSHolding(s) in Company
7th Nov 20231:47 pmRNSStatement re 2023 AGM Remuneration Report Vote
3rd Nov 202310:38 amRNSDirector Declaration
27th Oct 20239:56 amRNSHolding(s) in Company
23rd Oct 20234:14 pmRNSHolding(s) in Company
20th Oct 202310:36 amRNSHolding(s) in Company
18th Oct 20234:04 pmRNSHolding(s) in Company
18th Oct 20234:02 pmRNSHolding(s) in Company
18th Oct 202312:38 pmRNSDirector/PDMR Shareholding
18th Oct 20237:00 amRNSTrading Statement
17th Oct 202311:52 amRNSHolding(s) in Company
6th Oct 20233:39 pmRNSHolding(s) in Company
4th Oct 20233:41 pmRNSDirector/PDMR Shareholding
2nd Oct 20231:08 pmRNSHolding(s) in Company
17th Aug 20237:00 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.